{"columns": ["cmem_t_edit_distance", "cmem_t_is_updated", "cmem_t_memory_len", "cmem_t_memory_str", "cmem_t_memory_str_len"], "data": [[NaN, NaN, 5.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.", 298.0], [91.0, true, 6.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.", 358.0], [90.0, true, 7.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.", 439.0], [100.0, true, 7.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.", 439.0], [100.0, true, 7.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.", 439.0], [91.0, true, 8.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nTumor size is determined by the largest dimension, even if the shape is irregular.", 522.0], [100.0, true, 8.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nTumor size is determined by the largest dimension, even if the shape is irregular.", 522.0], [91.0, true, 9.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).", 631.0], [93.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).", 722.0], [89.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 897.0], [91.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nThe T stage is based on the largest dimension of the tumor.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 897.0], [89.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT1a corresponds to a tumor size of 0.1 to 0.5 cm.\nT1b corresponds to a tumor size of 0.6 to 1.0 cm.\nT1c corresponds to a tumor size of 1.1 to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 987.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT1a corresponds to a tumor size of 0.1 to 0.5 cm.\nT1b corresponds to a tumor size of 0.6 to 1.0 cm.\nT1c corresponds to a tumor size of 1.1 to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 987.0], [92.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 837.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 837.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 837.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.", 837.0], [94.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nT2 corresponds to a tumor size of 2.1 to 5.0 cm.\nT3 corresponds to a tumor size of 5.1 to 10.0 cm.\nT4 corresponds to a tumor size of more than 10.0 cm or with direct extension to the chest wall or skin.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 941.0], [88.0, true, 9.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 738.0], [100.0, true, 9.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.", 738.0], [95.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.", 821.0], [93.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10 (e.g. 40 mm is equal to 4.0 cm).\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 945.0], [98.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 913.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 913.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 913.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 913.0], [100.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 913.0], [97.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nT3 corresponds to a tumor size greater than 5.0 cm.", 965.0], [95.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nT2 corresponds to a tumor size of greater than 2.0 cm but not greater than 5.0 cm.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 965.0], [84.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [97.0, true, 11.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.", 888.0], [97.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [100.0, true, 10.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.", 830.0], [91.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.", 988.0], [100.0, true, 12.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.", 988.0], [97.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.", 1046.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.", 1046.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.", 1046.0], [96.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1131.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1131.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1131.0], [98.0, true, 15.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nT3 corresponds to a tumor size greater than 5.0 cm.", 1183.0], [98.0, true, 16.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nT3 corresponds to a tumor size greater than 5.0 cm.\nTumors with a size of 7 cm or more are classified as T4.", 1240.0], [97.0, true, 15.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors with a size of 7 cm or more are classified as T4.", 1188.0], [98.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nT2 corresponds to a tumor size between 2.1 cm and 5.0 cm.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1131.0], [97.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [97.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors that invade the skin beyond the mammary fascia are classified as T4b.", 1150.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors that invade the skin beyond the mammary fascia are classified as T4b.", 1150.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors that invade the skin beyond the mammary fascia are classified as T4b.", 1150.0], [97.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [95.0, true, 15.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors with a diameter greater than 10 cm are classified as T4.\nTumors with skin ulceration are classified as T4b.", 1188.0], [98.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors with a diameter greater than 10 cm are classified as T4.", 1137.0], [100.0, true, 14.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.\nTumors with a diameter greater than 10 cm are classified as T4.", 1137.0], [97.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0], [100.0, true, 13.0, "T stage is determined by the size of the tumor.\nT1 corresponds to a tumor size of up to 2.0 cm.\nTumor size is determined by the largest dimension, even if the shape is irregular.\nTumor size in millimeters can be converted to centimeters by dividing by 10.\nThe T stage is not affected by the presence or absence of lymph node metastasis.\nThe T stage is not affected by the presence or absence of ductal carcinoma in situ (DCIS).\nThe T stage is not affected by the presence or absence of hormone receptors (estrogen or progesterone).\nThe T stage is not affected by the HER2/neu gene amplification status.\nThe T stage does not consider the presence or absence of myoepithelial cells or cytokeratin expression.\nTumors with multifocal or multicentric disease are staged as the largest tumor size, with the addition of the 'm' modifier.\nTumors that involve the skin are classified as T4.\nT4 tumors are further classified based on the presence or absence of ulceration and the depth of invasion.\nThe T stage is not affected by the presence or absence of lymphovascular permeation.", 1073.0]]}